tacrine has been researched along with Cognitive Decline in 3 studies
Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Li, Q | 1 |
Chen, Y | 2 |
Xing, S | 1 |
Liao, Q | 1 |
Xiong, B | 1 |
Wang, Y | 1 |
Lu, W | 1 |
He, S | 1 |
Feng, F | 1 |
Liu, W | 1 |
Sun, H | 1 |
Bi, A | 1 |
An, W | 1 |
Wang, C | 2 |
Hua, Y | 1 |
Fang, F | 1 |
Dong, X | 1 |
Chen, R | 1 |
Zhang, Z | 1 |
Luo, L | 1 |
Chen, H | 1 |
Xiang, S | 1 |
Huang, L | 1 |
Lin, J | 1 |
Hu, S | 1 |
Mak, SH | 1 |
Wang, Q | 1 |
Cui, W | 1 |
Han, Y | 1 |
3 other studies available for tacrine and Cognitive Decline
Article | Year |
---|---|
Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection.
Topics: Amyloid beta-Peptides; Animals; Binding Sites; Butyrylcholinesterase; Cell Survival; Cholinesterase | 2021 |
SCR-1693 inhibits tau phosphorylation and improves insulin resistance associated cognitive deficits.
Topics: Animals; Cell Line, Tumor; Cognitive Dysfunction; Dose-Response Relationship, Drug; Insulin Resistan | 2020 |
Tacrine(10)-hupyridone, a dual-binding acetylcholinesterase inhibitor, potently attenuates scopolamine-induced impairments of cognition in mice.
Topics: Animals; Behavior, Animal; Cholinesterase Inhibitors; Cognitive Dysfunction; Disease Models, Animal; | 2018 |